strongly with insulin resistance. Excess upper body fat can accumulate either
intraperitoneally (visceral fat) or subcutaneously. Many investigators claim that excess …

Nowadays, HIV+ patients have an expected lifespan that is only slightly shorter than healthy
individuals. For this reason, along with the fact that infection can be acquired at a relatively …

Background Cardio-metabolic risk factors are of increasing concern in HIV-infected
individuals, particularly with the advent of antiretroviral therapy (ART) and the subsequent …

OBJECTIVE—Metabolic syndrome is a cluster of risk factors for cardiovascular disease and
type 2 diabetes. Definitions exist to identify those “at risk.” Treatment of HIV infection with …

Background: The health implications of weight gain after antiretroviral therapy (ART) for HIV
infection are not well characterized and may differ from weight gain among uninfected …

Effective highly active antiretroviral therapy (HAART) for human immunodeficiency virus-1
(HIV) infection has led to marked improvement in life-expectancy for those infected with HIV …

Background. The association between the use of highly active antiretroviral therapy
(HAART) and an increased risk of metabolic syndrome and cardiovascular disease remains …

Metabolic syndrome (MetS) is a constellation of risk factors including insulin resistance,
central obesity, dyslipidemia and hypertension that markedly increase the risk of Type 2 …

The success of highly active antiretroviral therapy (HAART) has determined a dramatic
decline in AIDS-and immunodeficiency-related causes of death in the HIV-infected …

Background: Metabolic syndrome (MS) identifies individuals at risk of cardiovascular
disease (CVD) and type 2 diabetes mellitus (T2DM). Little is known about MS and its …